KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Work In Process (2018 - 2022)

Historic Work In Process for TherapeuticsMD (TXMD) over the last 5 years, with Q3 2022 value amounting to $218000.0.

  • TherapeuticsMD's Work In Process fell 6831.4% to $218000.0 in Q3 2022 from the same period last year, while for Sep 2022 it was $218000.0, marking a year-over-year decrease of 6831.4%. This contributed to the annual value of $1.6 million for FY2021, which is 8346.37% up from last year.
  • As of Q3 2022, TherapeuticsMD's Work In Process stood at $218000.0, which was down 6831.4% from $1.7 million recorded in Q2 2022.
  • Over the past 5 years, TherapeuticsMD's Work In Process peaked at $1.7 million during Q2 2022, and registered a low of $83911.0 during Q3 2018.
  • Its 5-year average for Work In Process is $799184.1, with a median of $776347.0 in 2019.
  • As far as peak fluctuations go, TherapeuticsMD's Work In Process surged by 109838.28% in 2019, and later crashed by 6831.4% in 2022.
  • TherapeuticsMD's Work In Process (Quarter) stood at $339312.0 in 2018, then soared by 248.37% to $1.2 million in 2019, then decreased by 24.28% to $895000.0 in 2020, then surged by 83.46% to $1.6 million in 2021, then plummeted by 86.72% to $218000.0 in 2022.
  • Its Work In Process was $218000.0 in Q3 2022, compared to $1.7 million in Q2 2022 and $1.2 million in Q1 2022.